Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2009-08-14
Original SEC Filing: Click here

---

Webplus: SKBI/20090814/8-K/2_EX-99.1/000.htm SEC Original: v157945_ex99-1.htm
Skystar Bio-Pharmaceutical Announces Second Quarter 2009 Results XI’AN, CHINA August 14, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) SECOND QUARTER 2009 & RECENT HIGHLIGHTS Revenuesreased 39.4% year-over-year to $6.2 million Gross margin improved to 52.6% from 51.6% in the second quarter of 2008ome from operationsreased by 37.6% year-over-year to $1.7 million

---

---

Webplus: SKBI/20090814/8-K/1/000.htm SEC Original: v157945_8k.htm
Item 8.01 Other Events. On August 14, 2009,ystar Bio-Pharmaceuticalmpany issued a press release announcing its financial results for the three-month period ended June 30, 2009. Item 9.01 Number Description 99.1 Press Releaseted August 14, 2009ystar Bio-Pharmaceuticalmpany Bennet P. Tchaikovsky Chief Financial Officer v157945_8k.htm 1 8-K

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2009-08-14CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE